Header cover image
  • Investing Ideas
  • /
  • Australian Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record

Australian Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record

Results

2

0 new

These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.

2 companies

Neuren Pharmaceuticals

Market Cap: AU$2.5b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$19.39

7D

-2.2%

1Y

27.0%

Cryosite

Market Cap: AU$41.0m

Provides outsourced clinical trials logistic services in Australia.

CTE

AU$0.83

7D

-0.6%

1Y

4.4%